3.89 USD
↘ 0.01 (0.26%)PRE MARKET (AS OF 07:41 AM EDT)
Galectin Therapeutics Inc.
GALTNASDAQ • USD
Market: OPEN
Galectin Therapeutics Inc. (GALT) trades at $3.89 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (20.2%) and a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Oct 2, 2026.
Open?$3.84
High?$3.89
Low?$3.84
Prev. Close?$3.90
Volume?N/A
Avg. Volume?301.2K
Bid / Ask
Bid?$3.12 × 100
Ask?$4.59 × 100
Spread?$1.47
Midpoint?$3.86
Valuation & Ratios
Market Cap?393.3M
Shares Out?100.8M
Float?43.7M
Float %?66.3%
P/E Ratio?N/A
P/B Ratio?-2.84
EPS?-$0.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Employees
9
Market Cap
393.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2002-09-04
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD
NORCROSS, GA 30071
Phone: 678-620-3186
NORCROSS, GA 30071
Phone: 678-620-3186
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?-55.20Distress
Confidence?59%Low
Short InterestSqueeze Risk
Short % of Float?21.37%Squeeze Risk
Short Interest?9.3M
Days to Cover?25.2
Free Float43.7M
Avg Daily Volume371.0K
Settlement Date2026-09-15
Financial Health
Current Ratio?0.10Weak
Quick Ratio?0.10Weak
Cash Ratio?0.09Low
Debt/Equity?-0.24Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-2.84CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-26.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?20.2%STRONG▾
Peers50
S&P66
ROA?-189.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15889000
Enterprise Value?$413.1M
Fundamentals ratios updated end of day